FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称VOBRAMITAMAB TAVATECAN
异名/同义词IMMUNOGLOBULIN G1, ANTI-(HUMAN B7 HOMOLOG 3 PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL PRCA157 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PRCA157 .KAPPA.-CHAIN, DIMER, 297,297'-BIS(N-(2-(ACETYLAMINO)-4-O-(2-(ACETYLAMINO)-6-AZIDO-2,6-DIDEOXY-.BETA.-D-GALACTOPYRANOSYL)-2-DEOXY-6-O-R-.BETA.-D-GLUCOPYRANOSYL)-L-ASPARAGINE), WHERE R = (H OR 6-DEOXY-.ALPHA.-L-GALACTOPYRANOSYL), CLICK REACTION PRODUCT WITH 1,1'-(((((13-(1.ALPHA.,8.ALPHA.,9.BETA.)-BICYCLO(6.1.0)NON-4-YN-9-YL-9,9-DIOXIDO-1,11-DIOXO-2,5,12-TRIOXA-9-THIA-8,10-DIAZATRIDEC-1-YL)AMINO)SULFONYL)IMINO)BIS(2,1-ETHANEDIYLOXYCARBONYL))BIS(L-VALYL-N-(4-((((((1S,9S)-9-ETHYL-5-FLUORO-2,3,9,10,13,15-HEXAHYDRO-9-HYDROXY-4-METHYL-10,13-DIOXO-1H,12H-BENZO(DE)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-1-YL)AMINO)CARBONYL)OXY)METHYL)PHENYL)-L-ALANINAMIDE)
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD276 (B7H3, B7-H3, B7-RELATED PROTEIN 2, B7RP2, B7RP-2, B7 HOMOLOG 3, B7 HOMOLOGUE 3)), HUMANIZED MONOCLONAL ANTIBODY; CONJUGATED TO THE THE CAMPTOTHECIN DERIVATIVE EXATECAN VIA A LINKER (VOBRAMITAMAB TAVATECAN)
VOBRAMITAMAB TAVATECAN
VOBRAMITAMAB TAVATECAN [INN]
CAS登记号3036552-56-1
物质唯一标识(Unique Ingredient Identifier)6CAR6LS9JU
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System